Full F, van Gent M, Sparrer K, Chiang C, Zurenski M, Scherer M, et al. Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity. Nat Microbiol. 2019;4:164-176 pubmed 出版商

Wang H, Bu L, Wang C, Zhang Y, Zhou H, Zhang X, et al. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70. Cell Death Dis. 2018;9:734 pubmed 出版商

Kraus R, Yu X, Cordes B, Sathiamoorthi S, Iempridee T, Nawandar D, et al. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. PLoS Pathog. 2017;13:e1006404 pubmed 出版商

Li Y, Long X, Huang L, Yang M, Yuan Y, Wang Y, et al. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication. J Virol. 2016;90:887-903 pubmed 出版商

Nawandar D, Wang A, Makielski K, Lee D, Ma S, Barlow E, et al. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells. PLoS Pathog. 2015;11:e1005195 pubmed 出版商

Mansouri S, Pan Q, Blencowe B, Claycomb J, Frappier L. Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer. J Virol. 2014;88:11166-77 pubmed 出版商

CHENG A, Yockteng Melgar J, Jarvis M, Malik Soni N, Borozan I, Carpenter M, et al. Epstein-Barr virus BORF2 inhibits cellular APOBEC3B to preserve viral genome integrity. Nat Microbiol. 2019;4:78-88 pubmed 出版商

Guidry J, Myers J, Bienkowska Haba M, Songock W, Ma X, Shi M, et al. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes. J Virol. 2019;93: pubmed 出版商

Frisan T, Nagy N, Chioureas D, Terol M, Grasso F, Masucci M. A bacterial genotoxin causes virus reactivation and genomic instability in Epstein-Barr virus infected epithelial cells pointing to a role of co-infection in viral oncogenesis. Int J Cancer. 2019;144:98-109 pubmed 出版商

Bristol J, Djavadian R, Albright E, Coleman C, Ohashi M, Hayes M, et al. A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog. 2018;14:e1007179 pubmed 出版商

Zhang H, Tian J, Qi X, Xiang T, He G, Zhang H, et al. Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation. PLoS Pathog. 2018;14:e1007208 pubmed 出版商

Nawandar D, Ohashi M, Djavadian R, Barlow E, Makielski K, Ali A, et al. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. J Virol. 2017;91: pubmed 出版商

Zhang W, Han D, Wan P, Pan P, Cao Y, Liu Y, et al. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation. Sci Rep. 2016;6:34543 pubmed 出版商

Djavadian R, Chiu Y, Johannsen E. An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription. PLoS Pathog. 2016;12:e1005718 pubmed 出版商

Ma S, Xu X, Jones R, Delecluse H, Zumwalde N, Sharma A, et al. PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model. PLoS Pathog. 2016;12:e1005642 pubmed 出版商

Wille C, Nawandar D, Henning A, Ma S, Oetting K, Lee D, et al. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch. Proc Natl Acad Sci U S A. 2015;112:E7257-65 pubmed 出版商

Liu X, Cohen J. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase. J Virol. 2016;90:1129-38 pubmed 出版商

Quinn L, Zuo J, Abbott R, Shannon Lowe C, Tierney R, Hislop A, et al. Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle. PLoS Pathog. 2014;10:e1004322 pubmed 出版商

Sun X, Bristol J, Iwahori S, Hagemeier S, Meng Q, Barlow E, et al. Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells. J Virol. 2013;87:10126-38 pubmed 出版商

Mansouri S, Wang S, Frappier L. A role for the nucleosome assembly proteins TAF-I? and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation. PLoS ONE. 2013;8:e63802 pubmed 出版商

Raver R, Panfil A, Hagemeier S, Kenney S. The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1. J Virol. 2013;87:8053-63 pubmed 出版商

Hoebe E, Wille C, Hopmans E, Robinson A, Middeldorp J, Kenney S, et al. Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation. J Virol. 2012;86:11322-32 pubmed

Sivachandran N, Wang X, Frappier L. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol. 2012;86:6146-58 pubmed 出版商

Robinson A, Kwek S, Kenney S. The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1. PLoS Pathog. 2012;8:e1002516 pubmed 出版商

Robinson A, Kwek S, Hagemeier S, Wille C, Kenney S. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency. J Virol. 2011;85:8940-53 pubmed 出版商

Yu X, McCarthy P, Lim H, Iempridee T, Kraus R, Gorlen D, et al. The ZIIR element of the Epstein-Barr virus BZLF1 promoter plays a central role in establishment and maintenance of viral latency. J Virol. 2011;85:5081-90 pubmed 出版商

Bristol J, Robinson A, Barlow E, Kenney S. The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins. J Virol. 2010;84:12362-74 pubmed 出版商

Ellis Connell A, Iempridee T, Xu I, Mertz J. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J Virol. 2010;84:10329-43 pubmed 出版商

Yang E, Webster Marketon J, Chen M, Lo K, Kim S, Glaser R. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression. Brain Behav Immun. 2010;24:1089-96 pubmed 出版商

Ellis A, Wang Z, Yu X, Mertz J. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J Virol. 2010;84:6139-52 pubmed 出版商

Hagemeier S, Dickerson S, Meng Q, Yu X, Mertz J, Kenney S. Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase. J Virol. 2010;84:4383-94 pubmed 出版商

Angelova A, Aprahamian M, Balboni G, Delecluse H, Feederle R, Kiprianova I, et al. Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studies. Mol Ther. 2009;17:1164-72 pubmed 出版商

Dickerson S, Xing Y, Robinson A, Seaman W, Gruffat H, Kenney S. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters. PLoS Pathog. 2009;5:e1000356 pubmed 出版商

Li D, Qian L, Chen C, Shi M, Yu M, Hu M, et al. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. J Immunol. 2009;182:1799-809 pubmed 出版商

Jiang Y, Xu D, Zhao Y, Zhang L. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma. PLoS ONE. 2008;3:e1569 pubmed 出版商